University of Southern California
Los Angeles, California, 90089, United States
Location status: Recruiting
NCT Number: NCT06410157
Some types of meditation lead heart rate to become more steady as breathing quiets whereas others lead to large heart rate swings up and down (oscillations) as breathing becomes deeper and slower. The current study is designed to investigate how daily mindfulness practice with heart rate biofeedback during breathing in a pattern that either increases or decreases heart rate oscillation affect attention and memory and blood biomarkers associated with Alzheimer's disease.
Interested in participating?
Request Info50 year–70 year
All sexes
Interventional
Not applicable
Los Angeles, California, 90089, United States
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will be asked to undergo daily mindfulness practice while regulating (either increase or decrease) heart rate oscillation.
Time frame: Week 1 and Week 10
Plasma Ab42 levels will be compared for Week 1 (pre-intervention) and Week 10 (post-intervention). Investigators will test for a time X condition interaction in plasma Ab 42 levels (to assess group differences in change).
Time frame: Week 1 and Week 10
Plasma Ab40 levels will be compared for Week 1 (pre-intervention) and Week 10 (post-intervention). Investigators will test for a time X condition interaction in plasma Ab 40 levels (to assess group differences in change).
Time frame: Week 1 and Week 10
Investigators will test for a time X condition interaction with plasma Ab42/40 ratio values as the dependent variable (to assess group differences in change).
Time frame: Week 1 and Week 10
Investigators will test for a time X condition interaction with the ratio of pTau-181 and total tau values as the dependent variable (to assess group differences in change).
Time frame: Week 1 and Week 10
Investigators will test for a time X condition interaction in perivascular space volume.
Time frame: During intervention (daily during Weeks 2-10) and before intervention (daily during Week 1)
Investigators will compute a general learning factor across performance on all games played daily during the intervention period (Weeks 2-10) and separately across performance on all games played daily before the intervention period (Week 1). Investigators will test for group differences in performance during the intervention, controlling for performance before the intervention.
Time frame: Week 1 and Week 10
Investigators will test for a time x condition interaction in phasic LC responses to novel faces during an fMRI face-name task.
Contact information is provided by the study sponsor or research team.
University of Southern California
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05194787
Age-related Cognitive Decline, Alzheimer Disease
Hobart, Tasmania, Australia
View Trial DetailsNCT05602220
Age-related Cognitive Decline, Aging
Los Angeles, California, United States
View Trial DetailsNCT03848312
Age-related Cognitive Decline, Alzheimer Disease
Gainesville, Florida, United States
View Trial DetailsNCT02228187
Age-related Cognitive Decline, Alzheimer Disease
Singapore
View Trial Details